Enzyme inhibitors and uses thereof

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/55 (2006.01) A61K 31/382 (2006.01) A61K 31/4418 (2006.01) A61K 31/4433 (2006.01) A61P 25/28 (2006.01) C12N 9/99 (2006.01)

Patent

CA 2579768

The present invention relates to inhibitors of insulin-regulated aminopeptidase (IRAP) and methods for inhibiting same, as well as compositions comprising said inhibitors. In particular, the inhibitors of the present invention may be useful in therapeutic applications including enhancing memory and learning functions, regulating cellular glucose uptake and homeostasis, inducing labour and lactation, and other disorders or conditions wherein excessive or undesirable IRAP activity is implicated.

L'invention concerne des inhibiteurs de l'aminopeptidase régulées par l'insuline (IRAP) et des procédés pour les inhiber, ainsi que des compositions comprenant lesdits inhibiteurs. Les inhibiteurs de l'invention peuvent être utilisés, en particulier, dans des applications thérapeutiques comprenant l'amélioration de la mémoire et des fonctions d'apprentissage, la régulation de la fixation cellulaire du glucose et l'homéostasie, notamment le travail et la lactation, et d'autres troubles ou états pathologiques, dans lesquels une activité de l'IRAP est excessive ou non souhaitée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enzyme inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzyme inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme inhibitors and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1957888

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.